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Embryonic stem (ES) cell self-renewal is regulated by transcription factors, including Oct4, Sox2, and
Nanog. A number of additional transcriptional regulators of ES cell self-renewal have recently been identified,
including the orphan nuclear receptor estrogen-related receptor beta (Esrrb). However, the mode of action of
Esrrb in ES cells is unknown. Here, using an Oct4 affinity screen, we identify Esrrb as an Oct4 partner protein.
Esrrb can interact with Oct4 independently of DNA. Esrrb is recruited near the Oct-Sox element in the Nanog
proximal promoter, where it positively regulates Nanog expression. Esrrb recruitment to the Nanog promoter
requires both the presence of Oct4 and a degenerate estrogen-related receptor DNA element. Consistent with
its role in Nanog regulation, expression of the Esrrb protein within the Oct4-positive ES cell population is
mosaic and correlates with the mosaic expression of the Nanog protein. Together with previous reports that
Nanog may regulate Esrrb gene expression, our results suggest that Esrrb and Nanog act as part of a feedback
regulatory circuit that modulates the fluctuating self-renewal capacity of ES cell populations.
The self-renewal of mouse ES cells is regulated by a network
of transcription factors that includes Oct4, Nanog, and Sox2
(22). The expression level of Oct4 protein needs to be kept
within a tight range in order to maintain ES cell self-renewal
(23). Decreasing Oct4 levels below 50% induces differentiation
into the trophectoderm, whereas a twofold increase causes
differentiation into cells expressing markers of the endoderm
and mesoderm (23). In contrast, overexpression of Nanog al-
lows mouse embryonic stem (ES) cells to remain undifferen-
tiated in the absence of the otherwise requisite stimulation by
leukemia inhibitory factor and bone morphogenetic protein (5,
19, 34). Oct4 is thought to act together with Sox2 by binding to
adjacent cognate DNA sequences in many genes (1), including
Nanog (14, 26). Genome-wide chromatin immunoprecipitation
(ChIP) studies have suggested that composite Oct-Sox motifs
regulate the expression of many genes in mouse and human ES
cells (2, 16). Recent evidence has shown that the critical role of
Sox2 in maintaining ES cell self-renewal is regulating Oct4
expression, suggesting that the secondary role of gene regula-
tion via Oct-Sox motifs is performed redundantly with Sox4,
Sox11, and Sox15 (18).
Recent reports have expanded the list of factors that con-
tribute to ES cell self-renewal. Wang et al. (30) reported a
proteomic analysis of interactors of Oct4 and Nanog and
suggested that some Nanog interactors may assist in Nanog-
mediated gene regulation. A separate study using an RNA
interference (RNAi) screen found that depletion of estrogen-
related receptor beta (Esrrb), Tbx3, or Tcl1 resulted in ES cell
differentiation but that this differentiation could be attenuated
by overexpression of Nanog (13). However, it is unclear how
any of these novel regulatory factors mediate their function.
Here we use an unbiased analysis of Oct4 binding proteins to
identify Esrrb as an Oct4-interacting partner protein. We show
that Esrrb is recruited to the Oct4 responsive element within
the proximal Nanog promoter where it is responsible for me-
diating the positive regulatory effect of Oct4.
MATERIALS AND METHODS
Plasmids and cell culture. RNAi constructs pSuper-Esrrb-sh1 and pSuper-
Esrrb-sh2 were constructed by cloning Esrrb RNAi1 and RNAi2 (16) into
pSuper-puro (Oligoengine). pSuper-control contains an oligonucleotide without
complementarity to any known mammalian sequence (Dharmacon). Mouse ES
cell lines 46C (35) and ZHBTc4 (23) and derivatives of ZHBTc4 were grown on
gelatin-coated dishes without feeders on Glasgow minimal essential medium
supplemented with leukemia inhibitory factor, 15% fetal bovine serum, 0.25%
sodium bicarbonate, 1 mM glutamine, 1 mM sodium pyruvate, nonessential
amino acids, 50 M beta-mercaptoethanol, and penicillin-streptomycin.
Cells from the c6 cell line, called F-Oct4 ES cells from here onwards, were
created by electroporating ZHBTc4 cells with linearized pPyCAG (FLAG)3
Oct4IP, a plasmid in which the Oct4 open reading frame was placed between the
N-terminal triple FLAG tag and the internal ribosome entry site (IRES)-puro-
mycin resistance cassette of pPyCAG (FLAG)3IP (20). Electroporated cells were
plated in ES cell medium, and after 24 h, 1 g/ml puromycin and 1 g/ml
doxycycline were added. After 12 days of selection, puromycin-resistant colonies
were picked and tested for FLAG-Oct4 expression by anti-FLAG Western blot
analysis. TNG cells have been described previously (6) Puromycin-sensitive
TNG-PS cells were derived from TNG cells by excision of the frt-IRES-pac-frt
cassette by transient expression of FLPe. Bright field pictures of ES cell cultures
were taken using the IX70 inverted microscope (Olympus).
Oct4 purification and mass spectrometry. F-Oct4 ES cells and control cells
(ZHBTc4) were expanded to 50 14-cm dishes, plates were washed once with
phosphate-buffered saline, cells were scraped off, and nuclear extracts were
prepared (8) and dialyzed to 100 mM KCl (8). A total of 100 l of anti-FLAG
M2 agarose beads (Sigma), equilibrated in buffer C-100 (20 mM HEPES, pH 7.6,
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10% glycerol, 100 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 complete
EDTA-free protease inhibitor; Roche), was added to 10 ml of nuclear extract,
incubated for 3 h at 4°C, transferred into an Eppendorf tube, and washed five
times with 1 ml of C-100 buffer plus 0.02% NP-40 (C-100*) and eluted four times
with C-100* containing 0.2 mg/ml FLAG tripeptide (Sigma) for 15 min at 4°C.
Fractions were loaded onto a 10% sodium dodecyl sulfate (SDS)-phosphono-
acetic acid (PAA) gel and silver stained. Elutions 1 and 2, containing the majority
of FLAG-Oct4 in purification from the F-Oct4 extract, were concentrated by
SpeedVac condensation, loaded onto a 10% SDS-PAA gel, and stained with
colloidal Coomassie blue. Gel lanes were cut and subjected to in-gel digestion
with trypsin (Promega), essentially as described previously (31). Nanoflow liquid
chromatography-tandem mass spectrometry was performed on a 1100 series
capillary liquid chromatography system (Agilent Technologies) coupled to an
LTQ-Orbitrap mass spectrometer (Thermo), as described previously (27). Da-
tabase searches to assign proteins to the found peptide fragmentation spectra
were performed using Mascot, as described previously (27).
IP. For immunoprecipitation (IP), 2.5 g of Oct4 antibody (N19; Santa Cruz
Biotechnology) or Esrrb antibody (R&D Systems) was added to 200 l of 46C ES
cell nuclear extract and incubated under rotation for 2 h at 4°C. A total of 1 U
Benzonase (Novagen) or 25 g/ml ethidium bromide was added where indicated.
The antibody-extract mixture was added to 20 l of protein G-Sepharose beads
(Amersham) blocked with 1% fish skin gelatin (Sigma) and 0.2 mg/ml chicken
egg albumin (Sigma) and rotated for another 90 min. Beads were washed four
times with 100 l of C-100* buffer and boiled in SDS loading dye.
RNAi and assays for Nanog expression. 46C ES cells were transfected with
pSuper-Esrrb-sh1, pSuper-Esrrb-sh2, or pSuper-control using Lipofectamine
2000 transfection reagent (Invitrogen). To measure the effect of Esrrb RNAi on
the endogenous mRNA and protein levels of Nanog, Oct4, and Esrrb, trans-
fected cells were selected with 1 g/ml puromycin for 48 h, starting at 24 h
posttransfection. RNA was isolated from these samples using Trizol (Invitrogen),
and mRNA levels were measured by performing real-time quantitative PCR
(qPCR) on an Opticon real-time PCR machine. Protein levels were measured by
Western blot analyses using antibodies against Nanog (6), Oct4, Esrrb, and lamin
B1 (Santa Cruz Biotechnology).
TNG-PS cells were transfected with pSuper-Esrrb-sh1, pSuper-Esrrb-sh2, or
pSuper-control, and transfected cells were selected with puromycin for 48 h,
starting at 24 h posttransfection. Green fluorescent protein (GFP) fluorescence
of the TNG cells was measured by using a FACSCalibur flow cytometer (Becton
Dickinson), as described previously (6).
For measuring the effect of Esrrb RNAi on expression from the Nanog pro-
moter, pNanog-Luc containing a Nanog promoter fragment from 2.5 kb to 50
bp (11) and pRenilla-TK (Promega) were cotransfected with the pSuper con-
structs. Renilla luciferase assays were done 48 h posttransfection using the dual
luciferase reporter system (Promega). The pNanog-Luc mutated Oct binding site
(mOS) and its control were described previously (26). pNanog-Luc constructs
with a mutant estrogen-related receptor response element (ERRE) contained
the mutation GGT to AAC in the ERRE sequence TCTGGGTCA in the Nanog
proximal promoter from 230 to 106, compared to the Nanog transcriptional
start, and were tested 24 h posttransfection.
ChIP. ChIP using formaldehyde cross-linking and Oct4 antibodies (sc-8628;
Santa Cruz Biotechnology) or Esrrb antibodies (R&D Systems) was done on 46C
ES cells, as described previously (2). Dual cross-linking ChIP using formaldehyde
and di(N-succinimidyl) glutarate (DSG) was performed on 46C and ZBHTc4 ES
cells, as described previously (24). qPCR analysis was performed using DNA
Engine Opticon 2. Relative enrichments were calculated by comparing the ChIP
efficiency of the region of interest to that of an unrelated region (Amylase).
Primers used to amplify the Nanog genomic region are as follows: 5 (550 to
462), CACAGGCTCTTTCTTCAGACTTG and TCTTGCTTGCTCTTCAC
ATTGG; Oct-Sox (215 to 60), TCCCTCCCTCCCAGTCTG and CCTCCT
ACCCTACCCACCC; and 3 (929 to 988), GGTAGAACCAAGAGGC
TGCT and CATCACAACACGCACCTGA. Primers used for Zfp42 are as
follows: 283 to 117, TGCATCCTCTGCTTGTGTAA and CAGAGCTGTC
CCCTTGTCT; Rest (3216 to 3071), CTCCCCTGGACAATAGCTTC and
CGTCCTTCATTTCCTCAGTG; Dppa3 (1770 to 1550), GATCCAGCTGG
TCTGAGCTA and GTGCAGGGATCATAGGAGTG; and Lefty1 (1264 to
1060), AAGCTGCAGACTTCATTCCA and CGGGGGATAGATGAAG
AAAC (21). Primers used for Amylase are as follows: CTCCTTGTACGGGT
TGGT and AATGATGTGCACAGCTGAA.
EMSAs. 293T cells were transfected with pPyCAGIP derivatives (20) express-
ing the cDNAs of FLAG-Esrrb, Oct4, or Sox2. After 24 h, cells were washed and
harvested in phosphate-buffered saline, resuspended in lysis buffer (50 mM
HEPES, pH 7.9, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 complete
EDTA-free protease inhibitor; Roche) and rotated at 4°C for 20 min. After being
microcentrifuged at 13,000 rpm for 10 min, supernatants were divided into
aliquots and stored at 80°C. The electrophoretic mobility shift assay (EMSA)
was carried out as described previously (7). The antibodies for the supershift
were added after the initial incubation for a further 10 min as follows: 2 g of
anti-Oct4 (sc-9081), 2 g of anti-Sox2 (sc-17320), or 1 g of FLAG M2 antibody
(Sigma).
Immunofluorescence. 46C ES cells were grown on coverslips coated with 0.1%
gelatin and stained with antibodies using a standard protocol. In short, cells were
fixed in 4% paraformaldehyde and incubated with antibodies against Nanog (6),
Oct4 (N19; Santa Cruz Biotechnology), and Esrrb (R&D Systems). Secondary
antibodies are from Dako (fluorescein isothiocyanate swine anti-rabbit anti-
body), Molecular Probes (Alexa Fluor 594 goat anti-mouse antibody) and Jack-
son ImmunoResearch Laboratories (fluorescein isothiocyanate rabbit anti-goat
antibody). Images were taken with an Axio Imager (Zeiss).
RESULTS
The Oct4 protein interacts with Esrrb. To identify the in-
teraction partners of the Oct4 protein in ES cells, we con-
structed an ES cell line where, under self-renewing conditions,
all Oct4 in the cell has an N-terminal triple FLAG tag (FLAG-
Oct4). The parental ZHBTc4 ES cell line (23) has both Oct4
alleles disrupted, and the only Oct4 protein in the cell is tran-
scribed from a doxycycline-suppressible transgene (Fig. 1A).
ZHBTc4 cells were transfected with a construct in which the
constitutive expression of FLAG-Oct4 is linked through an
IRES to puromycin resistance. Simultaneously, doxycycline
was added to the medium to repress the inducible Oct4 trans-
gene expression (23). After 12 days of growth, colonies were
picked and expanded into cell lines. All cell lines expressed a
protein of the same relative molecular weight that reacted with
an anti-FLAG antibody on Western blots (data not shown). As
the Oct4 level must be tightly regulated to allow continued
self-renewal (23), the survival of puromycin-resistant colonies
indicates that the FLAG-Oct4 protein is functional. Two of
these lines were further tested for their response to doxycycline
treatment, and both underwent efficient differentiation at
clonal density (Fig. 1B and C). The c6 cell line (F-Oct4 ES
cells) was taken forward for biochemical analysis.
F-Oct4 ES cells were expanded, nuclear extracts were pre-
pared, and the FLAG-Oct4 protein was purified using FLAG-
affinity technology (see Materials and Methods). Silver stain
analysis of a polyacrylamide gel containing the proteins puri-
fied from F-Oct4 extracts identified a major band and a minor
band running just above the 54,000-molecular-weight marker
(Fig. 2A). Both bands are recognized by a FLAG antibody and
are not present in purifications from control extracts, suggest-
ing that they represent the FLAG-Oct4 protein (Fig. 2B). No
other major bands were observed, indicating that Oct4 does
not purify as part of a major stoichiometric complex, despite
the mild purification conditions used. Mass spectrometry anal-
ysis of two independent purifications identified the presence of
Oct4 (10 unique peptides) and Esrrb (5 unique peptides) in
F-Oct4 samples but not in control samples. Indeed, Esrrb
could be detected by Western blot analysis in the F-Oct4 sam-
ple but not in the control (Fig. 2C). The interaction between
Esrrb and Oct4 was independently verified by co-IP from ex-
tracts of a different ES cell line, 46C, using antibodies against
endogenous Oct4 and Esrrb (Fig. 2D and E). Treatment of the
extract with Benzonase nuclease or ethidium bromide did not
affect the interaction (Fig. 2D and E), indicating that it is not
indirectly mediated through DNA.
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Moreover, the ability of bacterially expressed GST-Oct4 to
pull down FLAG-Esrrb from transfected ES cells (Fig. 2F)
indicates that posttranslational modification of Oct4 is not
required for interaction between Oct4 and Esrrb.
Esrrb regulates expression of the Oct4 target gene Nanog.
Oct4 regulates expression of a cohort of target genes in ES
cells, often acting in concert with Sox proteins (16). To deter-
mine whether the binding of Esrrb to Oct4 affected the regu-
lation of gene expression by Oct4, we first examined expression
of the Oct4 target gene Nanog. We depleted Esrrb by RNAi
using two vectors that express different, previously reported
Esrrb short hairpin RNAs (shRNAs) (16) and harbor a puro-
mycin selection marker. After 2 days of puromycin selection,
the levels of Nanog mRNA (Fig. 3A) and Nanog protein (Fig.
3B) were reduced in the 46C ES cells treated with either Esrrb
shRNA vector compared to the levels of the control. Impor-
tantly, this specific depletion of Nanog occurred prior to any
reduction in Oct4 expression (Fig. 3A and B) and prior to any
morphological evidence of ES cell differentiation (Fig. 3C).
This indicates that Esrrb shRNA-induced Nanog depletion is
not a consequence of differentiation but occurs prior to differ-
entiation. We also tested the effect of Esrrb depletion on
TNG-PS ES cells which have the GFP open reading frame
inserted at the start codon of one of the endogenous Nanog
alleles (6). Transfection of either Esrrb shRNA vector de-
creased the mean GFP fluorescence of the population (Fig.
3D) after 2 days of puromycin selection, suggesting that de-
pletion of Esrrb reduces transcription from the Nanog locus.
To determine whether Esrrb affects the activity of the Nanog
promoter, similar shRNA experiments were performed using a
luciferase reporter under the control of a Nanog promoter
fragment extending from 2.5 kb to 50 bp compared to the
transcription start site. Esrrb shRNA vectors were cotrans-
fected with the luciferase reporters, and luciferase activity was
measured 2 days posttransfection. Figure 3E shows that Nanog
promoter activity is strongly reduced with either Esrrb shRNA
vector compared to activity with a control shRNA vector.
Esrrb regulates Nanog expression using contacts with both
Oct4 and a degenerate ERRE. Oct4 contributes to the regula-
tion of Nanog by binding to an Oct-Sox site (14, 26), located
166 to 180 bp upstream of the mapped transcription start site
of the Nanog gene (4, 32). To investigate the relationship
between the regulation of Nanog by Esrrb and that by Oct4, we
performed ChIP experiments with antibodies for Oct4 and
Esrrb in 46C ES cells and examined the precipitates for the
presence of the Nanog promoter. A standard ChIP protocol
using only formaldehyde as a cross-linking agent confirms that
Oct4 binds in the vicinity of the Oct-Sox site (Fig. 4B). Using
standard ChIP, we found no enrichment of Esrrb at the Nanog
promoter (Fig. 4B), although the Esrrb protein is immunopre-
cipitated during the ChIP procedure (data not shown). Con-
ventional formaldehyde-based ChIP methods efficiently detect
protein-DNA interactions but may not detect the binding of
Esrrb to the Nanog promoter if it is stabilized by protein-
protein interactions. We therefore used a dual cross-linking
ChIP method (XX-ChIP) that uses DSG prior to formalde-
hyde cross-linking (24). DSG has a longer spacer arm than
formaldehyde and has been used to cross-link transcription
factor protein-protein interactions on DNA (15). XX-ChIP
indeed detects Esrrb at the Oct-Sox site within the proximal
FIG. 1. Construction and characterization of F-Oct ES cell lines.
(A) In ZHBTc4 ES cells, both the Oct4 alleles have been replaced and
Oct4 expression is directed from a doxycycline-suppressible transgene.
F-Oct ES cell lines were derived from ZHBTc4 cells by transfection
with linearized pPyCAG (FLAG)3 Oct4IP and the concomitant addi-
tion of doxycycline. (B) Clonal assays on two clones demonstrate that
following the withdrawal of doxycycline, Oct4-induced differentiation
occurs efficiently in representative F-Oct cell lines. Cells were plated at
600 cells per 10-cm dish in the presence or absence of 1 mM doxycy-
cline, cultured for 6 days, and stained for alkaline phosphatase activity,
and the differentiation status was determined. (C) Examples of colony
morphologies in the presence (Dx) and absence (Dx) of doxycy-
cline are shown.
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Nanog promoter (Fig. 4C). XX-ChIP using the Oct4 antibody
also gives a specific enrichment of Oct4 at the Oct-Sox motif
(Fig. 4C). Oct4 and Esrrb were also specifically enriched on the
Oct-Sox site compared to the input and an immunoglobulin G
control (data not shown). We conclude that Esrrb binds to the
Nanog promoter in the vicinity of the Oct-Sox motif.
To assess whether Esrrb binding to the Nanog promoter is
dependent on Oct4, we made use of the ES cell line ZHBTc4
in which the endogenous Oct4 alleles are disrupted and in
which Oct4 is expressed from a doxycycline-suppressible pro-
moter (23). The addition of doxycycline for 12 h removes all
Oct4 protein from the cell (Fig. 4D). At this time point, the
level of Esrrb is unaffected (Fig. 4D). Esrrb XX-ChIP shows
that Esrrb is no longer enriched at the Nanog promoter in the
absence of Oct4 (Fig. 4E). To functionally test whether the
maintenance of Nanog promoter activity by Esrrb is via Oct4,
we tested Nanog promoter-luciferase constructs where the
Oct4 binding site is mutated (Nanog mOS) (26). As expected,
the Nanog mOS reporter is less active than the wild-type (wt)
construct, although still clearly above the background (26)
(Fig. 4F). Depletion of Esrrb does not further reduce the
activity of Nanog mOS (Fig. 4F), suggesting that the effect of
Esrrb on Nanog expression requires Oct4 binding to the Oct-
Sox site in the Nanog promoter.
Estrogen-related receptors are thought to act via an ERRE.
A consensus ERRE of tcaaGGttca (invariant positions in up-
percase) was determined by SELEX and confirmed by in vivo
studies (9, 29). Visual inspection of the Nanog promoter iden-
tified a degenerate ERRE (sequence TCTGGGTCA) 12 bp
upstream of the Oct-Sox motif (Fig. 5A). This sequence is
largely conserved in many mammalian species (26). To test the
contribution of this putative ERRE to Nanog promoter activ-
ity, we mutated the core GGT in this motif into AAC (Fig. 5A)
in the context of a Nanog promoter-luciferase construct. Nu-
clear magnetic resonance structural analysis of the Esrrb DNA
binding domain in complex with DNA shows that these bases
make a major contribution to DNA binding by Esrrb (10). This
mutation strongly reduced Nanog promoter activity (Fig. 5B).
Moreover, in contrast to the situation with the unmutated
construct, the activity of this mutant could not be further re-
duced by Esrrb shRNA expression (Fig. 5B).
EMSA was employed to investigate the potential binding of
Esrrb to the Nanog promoter. A 57-mer oligonucleotide cor-
responding to the sequence of the Nanog promoter that in-
cludes the putative ERRE and the Oct-Sox site was used.
Lysate prepared from 293T cells that were cotransfected with
FLAG-Esrrb, Oct4, and Sox2 expression plasmids caused a
shift in migration of the probe into two complexes (Fig. 5C,
left). The faster migrating complex could be supershifted by
antibodies against Oct4 and Sox2 but not by an anti-FLAG
antibody. In contrast, the slower migrating band was super-
shifted by all three antibodies, suggesting that the slower mi-
grating complex is formed by binding of Esrrb, Sox2, and Oct4
(Fig. 5C, left, lanes 2 to 4). Using a second 57-mer oligonucle-
otide that has the GGT-to-AAC mutation in the putative
FIG. 2. Oct4 interacts with Esrrb. (A) Silver-stained SDS-PAA gel of peptide-eluted FLAG-Oct4 versus control purification. The protein
marker is shown as molecular weight (MW) in thousands. The band representing FLAG-Oct4 is indicated by the arrow. (B) Western blot analysis
with anti-FLAG antibody on input, supernatant (sup), and elution of FLAG-Oct4 purification. (C) Western blot analysis with anti-Esrrb antibody
on the eluted FLAG-Oct4 or control sample. (D, E) Co-IP experiments using antibodies against Oct4, Esrrb, or control immunoglobulin G (IgG)
confirm the Oct4-Esrrb interaction. DNA independency of the interaction is shown by its insensitivity to Benzonase (benzo) or ethidium bromide
(EtBr). (F) GST pulldown experiment using extracts from FLAG-Esrrb-transfected ES cells.
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ERRE, only the faster of the two complexes was observed, and
this could be shifted by antibodies against Oct4 and Sox2 but
not by anti-FLAG antibody (Fig. 5C, right). Therefore, we
conclude that there is an ERRE upstream of the Oct-Sox site
in the Nanog promoter that is essential for Esrrb binding and
optimal Nanog promoter activity.
To determine whether binding of Esrrb to the Nanog pro-
moter in vitro is dependent upon binding of Oct4-Sox2,
FIG. 3. Esrrb regulates Nanog expression. (A) Real-time qPCR analysis shows downregulation of the mRNA levels of Nanog but not Oct4, following
the shRNA-mediated knockdown of Esrrb in 46C ES cells by transfection of pSUPER plasmids expressing Esrrb shRNA1 or Esrrb shRNA2. RNA levels
are compared to cells transfected with pSUPER expressing a control shRNA. Error bars represent the standard error of the mean (SEM) of three
independent experiments. (B) Western blot analysis on total cell lysates confirms depletion at the protein level of Esrrb and Nanog, but not Oct4, upon
shRNA-mediated knockdown of Esrrb. One of two independent experiments is shown. Lamin B1 is used as loading control. (C) Phase-contrast images
of live 46C ES cell cultures 3 days after transfection of the indicated shRNA constructs. Scale bars represent 200 m. (D) Fluorescence-activated cell
sorter profiles of TNG-PS ES cells, in which the GFP open reading frame has been placed at the Nanog start codon. Knockdown of Esrrb with either
of two shRNA constructs reduces GFP expression compared to that of the control construct. E14/T is an ES cell line lacking a GFP gene. One of two
independent experiments is shown. (E) Luciferase reporter assays with a Nanog-promoter construct. The luciferase activity of the Nanog promoter (2.5
kb to 50 bp), cotransfected with control shRNA plasmid, is arbitrarily set at 10 and compared to the luciferase activities in the presence of either of
two Esrrb shRNA plasmids or of the pGL-Basic control vector. Error bars represent the SEM of three independent experiments.
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EMSAs were performed by mixing cell lysates prepared from
individual transfections of Oct4, Sox2, and Esrrb into 293T
cells. The addition of the Esrrb lysate caused a weak probe
shift (Fig. 5D, lanes 2 and 3), showing that Esrrb alone can
bind the Nanog promoter probe. However, in the presence of
Oct4 and Sox2, DNA complex formation by Esrrb was en-
hanced compared to DNA complex formation by Esrrb alone
(Fig. 5D, compare lanes 2 and 3 to lanes 6 and 7). This effect
was greatest with both Oct4 and Sox2 present, suggesting that
an Oct4-Sox2 complex is required for this cooperative effect.
Using different combinations of Esrrb, Oct4, and Sox2 lysates
leads to the same conclusions (Fig. 5D, bottom). These data,
together with the Esrrb ChIP experiments (Fig. 4C and E),
suggest a model (Fig. 5E) in which the presence of the Oct4-
Sox2 complex bound to the Oct-Sox site in the Nanog promoter
strongly enhances the intrinsic capacity of Esrrb to bind to an
ERRE located upstream of the Oct-Sox site.
Esrrb binds and regulates other Oct4 target genes. To de-
termine the generality of the association of Esrrb with Oct4 on
Oct4 target genes, we investigate a number of Oct4 target
genes with a characterized Oct-Sox DNA element (Fig. 6A),
using the ES cell line ZHBTc4. These genes all had a putative
FIG. 4. Esrrb binds to the Nanog promoter in an Oct4-dependent manner. (A) Outline of the Nanog genomic contig showing the amplicons
(5, Oct-Sox, and 3) used in ChIP analysis and size markers in base pairs. (B) ChIP analysis of formaldehyde cross-linked 46C ES cells using
antibodies against Oct4 and Esrrb. Relative enrichments of the Nanog amplicons are depicted as enrichments over that at an unrelated region
(Amylase). Oct4 binds to the Oct-Sox element, but no significant enrichment for Esrrb can be detected at this region. Error bars represent the
standard error of the mean (SEM) of two independent experiments. (C) ChIP analysis of dual cross-linked 46C ES cell chromatin shows
enrichment of both Oct4 and Esrrb on the Oct-Sox element of the Nanog promoter. Error bars for Esrrb enrichments represent the SEM of two
independent experiments. (D) Western blot analysis showing the complete depletion of Oct4 protein in ZHBTc4 ES cells after a 12-h treatment
with 1 g/ml doxycycline compared to that in untreated cells. Levels of Esrrb are not affected. Lamin B1 is used as a loading control. (E) Dual
cross-linked chromatin from ZHBTc4 ES cells that were untreated (Dox) or treated for 12 h with 1 g/ml doxycycline (Dox). Binding of Esrrb
to the Oct-Sox element is no longer detected when Oct4 is absent. Error bars represent the standard error of the mean (SEM) of two independent
experiments. (F) Luciferase assays with the wt Nanog promoter construct (Nanog-wt), with the mutated Oct binding site (Nanog-mOS) or with the
empty vector pGL-Basic. Cotransfected shRNA plasmids are indicated. Error bars represent the SEM of three independent experiments.
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ERRE at different distances from the Oct-Sox site and in
different orientations (Fig. 6A). XX-ChIP analysis showed that
Esrrb binds near the Oct-Sox element in the promoters of
Zfp42 (Rex1) and Rest but not near the Oct-Sox site of Dppa3
and Lefty1 (Fig. 6B). Interestingly, removing Oct4 from the
promoters by doxycycline treatment (Fig. 4D) prevented the
detection of Esrrb at the Rest promoter, whereas Esrrb binding
to the Zfp42 promoter was unaffected.
We next determined the contribution of Esrrb to the expres-
sion of Zfp42 and Rest by Esrrb knockdown. Expression of
FIG. 5. A degenerate ERRE binds Esrrb and is important for Nanog promoter activity. (A) Representation of the degenerate ERRE upstream
of the Oct-Sox site in the Nanog promoter. The generated mutation is indicated. (B) Luciferase reporter assays with a wt Nanog promoter construct
(wt ERRE) or mutated ERRE promoter construct (mut ERRE). Cotransfected shRNA plasmids are indicated. Error bars represent the standard
error of the mean of three independent experiments. (C) Cell lysates from 293T cells cotransfected with FLAG-Esrrb, Oct4, and Sox2 expression
plasmids were used in an EMSA with a 57-nucleotide Nanog promoter probe containing the Oct-Sox site sequence and a wt or mutated ERRE.
Antibodies were added as indicated. The complex of Esrrb-Oct4-Sox2 (E-O-S) is indicated. (D) Cell lysates from 293T cells transfected with
FLAG-Esrrb, Oct4, or Sox2 expression plasmids were subjected to EMSA using the wt Nanog promoter probe. (E) Model showing the
enhancement of Esrrb binding to the Nanog promoter by Oct4 and Sox2 which positively affects Nanog promoter activity.
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Esrrb shRNAs caused a reduction in Zfp42 mRNA expression,
whereas Rest mRNA expression was unaffected (Fig. 6C). We
conclude that Esrrb binds near the Oct-Sox sites of two other
Oct4 targets, Zfp42 and Rest, but that only in the case of Zfp42
does this binding contribute to its expression in ES cells.
Esrrb protein levels correlate with Nanog levels in ES cell
colonies. Oct4-positive (Oct4) ES cell colonies express Nanog
in a mosaic fashion (6, 12, 28). The cellular expression of Esrrb
was examined by immunostaining ES cells with antibodies
against Nanog or Esrrb. Interestingly, 46C ES cell colonies
show a mosaic pattern of Esrrb expression within the Oct4
population (Fig. 7A and B). Moreover, when cells are classified
according to their relative high, medium, or low levels of Esrrb
staining within ES cell colonies (Fig. 7A), there is a good
correlation between the levels of expression of Nanog and
those of Esrrb (Fig. 7C). This correlation between the cellular
levels of Esrrb and Nanog, in combination with our Nanog
gene regulation data, suggests that high Nanog expression in
the cell may be facilitated by high Esrrb expression.
DISCUSSION
Using an Oct4 protein affinity strategy, we have identified
Esrrb as a binding partner of the Oct4 protein. A previous
report identified a number of other putative Oct4 interacting
proteins but did not detect Esrrb (30). Our approach also
identified a number of the reported interactors in our Oct4
sample, but these were often also present in the control sam-
ple. Our milder purification conditions may account for both
the reproducible and verified identification of Esrrb as a spe-
cific Oct4 binding partner and the nonspecific binding of other
reported interactors. Indeed, we find that Oct4-Esrrb interac-
tion is sensitive to conditions with higher levels of salt (data not
shown).
Members of the estrogen-related receptor family can bind to
the palindromic 12-bp estrogen response element (25) or to
the “extended half-site” 9-bp ERRE (9, 29). Either element
can support Esrrb-mediated transcription (17, 33). Esrrb was
also suggested to activate targets genes independently of a
DNA element by binding to transcription factors, such as Sp1
(3). We show here, using ChIP and EMSAs, that Esrrb recruit-
ment to the Nanog promoter requires both a degenerate, but
conserved, ERRE and binding of Oct4 to the downstream
Oct-Sox element. EMSAs (Fig. 5) confirm the previously re-
ported synergistic binding of Oct4 and Sox2 to the Oct-Sox site
(14), but also indicate that binding of Esrrb to the Nanog
promoter oligonucleotides occurs cooperatively with binding
of Oct4 and Sox2. This effect required binding of both Oct4
and Sox2.
We also provide evidence that recruitment of Esrrb to the
Nanog promoter by Oct4 and the ERRE positively regulates
Nanog expression. Depletion of Esrrb with shRNAs caused
transcriptional downregulation of the endogenous Nanog gene
and a Nanog promoter-reporter. Mutation of the ERRE also
FIG. 6. Esrrb binds and regulates other Oct4 target genes. (A) The sequences surrounding the Oct-Sox motifs in the regulatory elements of
the Nanog, Zfp42, Rest, Dppa3, and Lefty1 genes are shown with the position and orientation of the putative ERREs indicated. The distance from
the 3 nucleotide of the shown Oct motif to the transcription start site is indicated. (B) ChIP with anti-Oct4 or anti-Esrrb antibodies on dual
cross-linked chromatin isolated from ZHBTc4 cells that were either untreated (Dx) or treated for 12 h with 1 g/ml doxycycline (Dx) to
downregulate Oct4 expression. Enrichments over that at a negative control region (Amylase) are depicted; error bars represent standard error of
the mean (SEM) of two independent experiments. (C) qPCR analysis of transcript levels in cells transfected with control or Esrrb shRNA. Error
bars represent SEM of two independent experiments.
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had a negative effect on reporter expression, underscoring the
importance of the ERRE for the functional recruitment of
Esrrb to the Nanog promoter.
Based upon the effect of mutations within the composite
Oct-Sox site upon reporter gene expression directed by the
proximal Nanog promoter, Oct4 has been suggested to be
important for maintaining Nanog expression in ES cells (14,
26). However, Oct4 is not required to initiate Nanog expression
in the preimplantation embryo, since Nanog transcripts (5) are
present in Oct4/ morulae and early blastocysts. This appar-
ent discrepancy could be due, in part, to different requirements
for establishment versus maintenance of Nanog expression.
Our data on the Esrrb requirement for Nanog expression in ES
cells suggest that one function of Oct4 binding to the Oct-Sox
motif is that it facilitates Esrrb binding to the Nanog promoter,
which in turn promotes Nanog transcription in ES cells.
Transcriptional regulation via transcription factor interac-
tions in ES cell self-renewal. Here we have provided evidence
of a stem cell factor, Oct4, directing its physical interactor,
Esrrb, to a target gene, Nanog, to positively regulate transcrip-
tion. Gene regulation facilitated by complexes of individual
transcription factors, like the Oct4-Esrrb complex, may be
widespread in ES cells. Visual inspection of the sequences
around the Oct-Sox sites of a number of Oct-Sox target genes
for homology to the ERRE identified several potential Esrrb
targets that were tested for regulation by Esrrb. Of these, ChIP
analysis showed Esrrb to be detectable on Zfp42 and Rest but
not Lefty1 or Dppa3. The Oct4-independent binding of Esrrb
to the Zfp42 promoter may be due to the high match of the
Zfp42 ERRE sequence to the consensus (8/9) (Fig. 6A), which
may provide sufficient DNA binding affinity. The extreme prox-
imity of the ERRE and Oct sites in Rest coupled with the low
match to the ERRE consensus (6/9) could underlie the Oct4-
dependent ChIP of Esrrb at Rest. However, the ERRE in
Nanog is further removed from the Oct-Sox site and is a better
match to the consensus (7/9) than that in Rest, so there is no
obvious common feature that can explain the Oct4-dependent
binding of Esrrb to each of these sequences. There is also no
clear reason why the remaining two Oct-Sox targets do not
bind Esrrb. A low match to the consensus could explain the
lack of binding to Dppa3 (6/9). However, the consensus match
for Lefty1 is the same as that for Nanog (7/9), suggesting that
relative spatial disposition and/or distance could play a role.
Further experimentation will be required to more deeply un-
derstand the relationship of Oct4 and Esrrb binding to DNA
and how this affects gene regulation.
Nanog is expressed mosaically within the Oct4 populations
in ES cell cultures (6, 12, 28). Moreover, Nanog levels fluctuate
FIG. 7. Esrrb protein levels in cells cofluctuate with Nanog protein levels. (A) Staining of ES cells with Esrrb antibody and Nanog antibody.
Antibodies and DAPI staining are as indicated. Arrows point to cells that were assigned to have high (H), medium (M), or low (L) levels of Esrrb
or Nanog. (B) Staining of ES cells with Esrrb antibody and Oct4 antibody. Antibodies and DAPI staining are as indicated. (C) Quantification of
the percentage of cells that have high, medium, or low levels of Nanog or Esrrb. Error bars indicate the standard error of the mean of two
independent experiments, in which 350 and 400 cells were assessed, respectively.
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in ES cell cultures such that cells expressing a low level or no
Nanog can reexpress a high level of Nanog. However, lowered
Nanog expression predisposes cells toward differentiation,
without marking a commitment event (6). Here we show that
the mosaic patterns of Esrrb and Nanog expression in ES cell
colonies largely overlap. We also show that Esrrb positively
regulates Nanog expression. As Nanog has been reported to
positively regulate Esrrb expression (16), Esrrb and Nanog
may both act to reinforce expression of the reciprocal gene
through a positive feedback loop. How this leads to mosaic and
cofluctuating levels of both proteins remains to be determined.
Oct4 is not obviously mosaic and appears not to fluctuate,
suggesting that it is not a determining factor of fluctuations in
Nanog and Esrrb in ES cells. As Nanog levels and, by impli-
cation, Esrrb levels regulate the self-renewal efficiency of ES
cells, unraveling this regulatory mechanism will be important
for a fuller understanding of ES cell self-renewal and the main-
tenance of pluripotency.
ACKNOWLEDGMENTS
We thank Hitoshi Niwa for ZHBTc4 cells, Austin Cooney for the
2.5-kb Nanog promoter-luciferase construct, Paul Robson for the
Nanog mOS luciferase and control Nanog luciferase constructs, Austin
Smith for 46C ES cells, Rodrigo Osorno for technical assistance, and
Frank Grosveld for critically reading the manuscript and for helpful
suggestions.
This work was supported by an NWO Vidi grant to the R.P. labo-
ratory and by the Medical Research Council and the Biotechnological
and Biological Sciences Research Councils of the United Kingdom,
the Wellcome Trust, and the Juvenile Diabetes Research Foundation.
REFERENCES
1. Ambrosetti, D. C., C. Basilico, and L. Dailey. 1997. Synergistic activation of
the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on
protein-protein interactions facilitated by a specific spatial arrangement of
factor binding sites. Mol. Cell. Biol. 17:6321–6329.
2. Boyer, L. A., T. I. Lee, M. F. Cole, S. E. Johnstone, S. S. Levine, J. P. Zucker,
M. G. Guenther, R. M. Kumar, H. L. Murray, R. G. Jenner, D. K. Gifford,
D. A. Melton, R. Jaenisch, and R. A. Young. 2005. Core transcriptional
regulatory circuitry in human embryonic stem cells. Cell 122:947–956.
3. Castet, A., A. Herledan, S. Bonnet, S. Jalaguier, J. M. Vanacker, and V.
Cavailles. 2006. Receptor-interacting protein 140 differentially regulates es-
trogen receptor-related receptor transactivation depending on target genes.
Mol. Endocrinol. 20:1035–1047.
4. Chambers, I. 2005. Mechanisms and factors in embryonic stem cell renewal.
Rend. Fis. Acc. Lincei 16:83–97.
5. Chambers, I., D. Colby, M. Robertson, J. Nichols, S. Lee, S. Tweedie, and A.
Smith. 2003. Functional expression cloning of Nanog, a pluripotency sus-
taining factor in embryonic stem cells. Cell 113:643–655.
6. Chambers, I., J. Silva, D. Colby, J. Nichols, B. Nijmeijer, M. Robertson, J.
Vrana, K. Jones, L. Grotewold, and A. Smith. 2007. Nanog safeguards
pluripotency and mediates germline development. Nature 450:1230–1234.
7. Chew, J.-L., Y.-H. Loh, W. Zhang, X. Chen, W.-L. Tam, L.-S. Yeap, P. Li,
Y.-S. Ang, B. Lim, P. Robson, and H.-H. Ng. 2005. Reciprocal transcriptional
regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem
cells. Mol. Cell. Biol. 25:6031–6046.
8. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcrip-
tion initiation by RNA polymerase II in a soluble extract from isolated
mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
9. Dufour, C. R., B. J. Wilson, J. M. Huss, D. P. Kelly, W. A. Alaynick, M.
Downes, R. M. Evans, M. Blanchette, and V. Giguere. 2007. Genome-wide
orchestration of cardiac functions by the orphan nuclear receptors ERR
and . Cell Metab. 5:345–356.
10. Gearhart, M. D., S. M. Holmbeck, R. M. Evans, H. J. Dyson, and P. E.
Wright. 2003. Monomeric complex of human orphan estrogen related re-
ceptor-2 with DNA: a pseudo-dimer interface mediates extended half-site
recognition. J. Mol. Biol. 327:819–832.
11. Gu, P., D. LeMenuet, A. C.-K. Chung, M. Mancini, D. A. Wheeler, and A. J.
Cooney. 2005. Orphan nuclear receptor GCNF is required for the repression
of pluripotency genes during retinoic acid-induced embryonic stem cell dif-
ferentiation. Mol. Cell. Biol. 25:8507–8519.
12. Hatano, S. Y., M. Tada, H. Kimura, S. Yamaguchi, T. Kono, T. Nakano, H.
Suemori, N. Nakatsuji, and T. Tada. 2005. Pluripotential competence of cells
associated with Nanog activity. Mech. Dev. 122:67–79.
13. Ivanova, N., R. Dobrin, R. Lu, I. Kotenko, J. Levorse, C. DeCoste, X.
Schafer, Y. Lun, and I. R. Lemischka. 2006. Dissecting self-renewal in stem
cells with RNA interference. Nature 442:533–538.
14. Kuroda, T., M. Tada, H. Kubota, H. Kimura, S.-Y. Hatano, H. Suemori, N.
Nakatsuji, and T. Tada. 2005. Octamer and Sox elements are required for
transcriptional cis regulation of Nanog gene expression. Mol. Cell. Biol.
25:2475–2485.
15. Liu, T., A. E. Tee, A. Porro, S. A. Smith, T. Dwarte, P. Y. Liu, N. Iraci, E.
Sekyere, M. Haber, M. D. Norris, D. Diolaiti, G. Della Valle, G. Perini, and
G. M. Marshall. 2007. Activation of tissue transglutaminase transcription by
histone deacetylase inhibition as a therapeutic approach for Myc oncogen-
esis. Proc. Natl. Acad. Sci. USA. 104:18682–18687.
16. Loh, Y. H., Q. Wu, J. L. Chew, V. B. Vega, W. Zhang, X. Chen, G. Bourque,
J. George, B. Leong, J. Liu, K. Y. Wong, K. W. Sung, C. W. Lee, X. D. Zhao,
K. P. Chiu, L. Lipovich, V. A. Kuznetsov, P. Robson, L. W. Stanton, C. L.
Wei, Y. Ruan, B. Lim, and H. H. Ng. 2006. The Oct4 and Nanog transcription
network regulates pluripotency in mouse embryonic stem cells. Nat. Genet.
38:431–440.
17. Lu, D., Y. Kiriyama, K. Y. Lee, and V. Giguere. 2001. Transcriptional regu-
lation of the estrogen-inducible pS2 breast cancer marker gene by the ERR
family of orphan nuclear receptors. Cancer Res. 61:6755–6761.
18. Masui, S., Y. Nakatake, Y. Toyooka, D. Shimosato, R. Yagi, K. Takahashi, H.
Okochi, A. Okuda, R. Matoba, A. A. Sharov, M. S. Ko, and H. Niwa. 2007.
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse
embryonic stem cells. Nat. Cell Biol. 9:625–635.
19. Mitsui, K., Y. Tokuzawa, H. Itoh, K. Segawa, M. Murakami, K. Takahashi,
M. Maruyama, M. Maeda, and S. Yamanaka. 2003. The homeoprotein
Nanog is required for maintenance of pluripotency in mouse epiblast and ES
cells. Cell 113:631–642.
20. Mullin, N. P., A. Yates, A. J. Rowe, B. Nijmeijer, D. Colby, P. N. Barlow,
M. D. Walkinshaw, and I. Chambers. 2008. The pluripotency rheostat Nanog
functions as a dimer. Biochem. J. 411:227–231.
21. Nakatake, Y., N. Fukui, Y. Iwamatsu, S. Masui, K. Takahashi, R. Yagi, K.
Yagi, J.-I. Miyazaki, R. Matoba, M. S. H. Ko, and H. Niwa. 2006. Klf4
cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in
embryonic stem cells. Mol. Cell. Biol. 26:7772–7782.
22. Niwa, H. 2007. How is pluripotency determined and maintained? Develop-
ment 134:635–646.
23. Niwa, H., J. Miyazaki, and A. G. Smith. 2000. Quantitative expression of
Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.
Nat. Genet. 24:372–376.
24. Nowak, D. E., B. Tian, and A. R. Brasier. 2005. Two-step cross-linking
method for identification of NF-kappaB gene network by chromatin immu-
noprecipitation. BioTechniques 39:715–725.
25. Pettersson, K., K. Svensson, R. Mattsson, B. Carlsson, R. Ohlsson, and A.
Berkenstam. 1996. Expression of a novel member of estrogen response
element-binding nuclear receptors is restricted to the early stages of chorion
formation during mouse embryogenesis. Mech. Dev. 54:211–223.
26. Rodda, D. J., J.-L. Chew, L.-H. Lim, Y.-H. Loh, B. Wang, H.-H. Ng, and P.
Robson. 2005. Transcriptional regulation of Nanog by OCT4 and SOX2.
J. Biol. Chem. 280:24731–24737.
27. Sa´nchez, C., I. Sa´nchez, J. A. Demmers, P. Rodriguez, J. Strouboulis, and M.
Vidal. 2007. Proteomics analysis of Ring1B/Rnf2 interactors identifies a
novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6
interacting corepressor. Mol. Cell. Proteomics 6:820–834.
28. Singh, A. M., T. Hamazaki, K. E. Hankowski, and N. Terada. 2007. A
heterogeneous expression pattern for Nanog in embryonic stem cells. Stem
Cells 25:2534–2542.
29. Sladek, R., J.-A. Bader, and V. Giguere. 1997. The orphan nuclear receptor
estrogen-related receptor  is a transcriptional regulator of the human me-
dium-chain acyl coenzyme A dehydrogenase gene. Mol. Cell. Biol. 17:5400–
5409.
30. Wang, J., S. Rao, J. Chu, X. Shen, D. N. Levasseur, T. W. Theunissen, and
S. H. Orkin. 2006. A protein interaction network for pluripotency of embry-
onic stem cells. Nature 444:364–368.
31. Wilm, M., A. Shevchenko, T. Houthaeve, S. Breit, L. Schweigerer, T. Fotsis,
and M. Mann. 1996. Femtomole sequencing of proteins from polyacrylamide
gels by nano-electrospray mass spectrometry. Nature 379:466–469.
32. Wu, D. Y., and Z. Yao. 2005. Isolation and characterization of the murine
Nanog gene promoter. Cell Res. 15:317–324.
33. Xie, W., H. Hong, N. N. Yang, R. J. Lin, C. M. Simon, M. R. Stallcup, and
R. M. Evans. 1999. Constitutive activation of transcription and binding of
coactivator by estrogen-related receptors 1 and 2. Mol. Endocrinol. 13:2151–
2162.
34. Ying, Q. L., J. Nichols, I. Chambers, and A. Smith. 2003. BMP induction of
Id proteins suppresses differentiation and sustains embryonic stem cell self-
renewal in collaboration with STAT3. Cell 115:281–292.
35. Ying, Q. L., M. Stavridis, D. Griffiths, M. Li, and A. Smith. 2003. Conversion
of embryonic stem cells into neuroectodermal precursors in adherent mo-
noculture. Nat. Biotechnol. 21:183–186.
VOL. 28, 2008 Esrrb REGULATES Nanog EXPRESSION 5995
